Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001209191-23-043165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-21 | 2023-07-19+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.01 | -4,107 | 528.0K | -0.8% | -$65.8K |
| DM | 2023-07-21 | 2023-07-19+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +4,107 | 531.9K | +0.8% | +$2,505 |
| DM | 2023-07-21 | 2023-07-19+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -4,107 | 133.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-19 | S | D | 207 | $16.08 | 527,981 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-19 | M | A | 207 | $0.61 | 528,188 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-21 | M | A | 3,900 | $0.61 | 531,881 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-21 | S | D | 3,900 | $16.01 | 527,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-07-19 | M | D | 207 | $0.00 | 137,403 | D | $0.61 · — to 2030-01-26 | 207 Common Stock | (F3) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-07-21 | M | D | 3,900 | $0.00 | 133,503 | D | $0.61 · — to 2030-01-26 | 3,900 Common Stock | (F3) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |